Supplementation of Glutamine and Fish Oil Versus Placebo in Patients With Heart Failure
Completed · Phase 2/Phase 3 · Has a placebo group
Conditions studied: Heart Failure
In brief
The aim of this study is to determine whether supplementation of glutamine and fish oil can improve peripheral skeletal muscle function and metabolism in patients with heart failure. The investigators propose a randomized, double-blind, placebo controlled study comparing the combined supplementation of fish oil and glutamine with placebo in patients with stable heart failure. 30 patients with heart failure will be randomized to either receiving 6.5 g fish oil/d and 8 g glutamine/d (n=15) or placebo (n=15) for 90 days. The primary outcome in this study is the change in muscle functional capacity measured as changes in maximum muscle strength and fatigability, peak VO2 and exercise time after supplementation. A secondary outcome is the measurement of systemic and local markers of inflammation.
Key facts
- Study ID
- NCT01534663
- Run by
- Columbia University
- People needed
- 31
- Starts
- 2011-11-01
- Expected to finish
- 2014-07-01
- Last updated by the study team
- 2020-12-22
Who can join
Age: 35 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- age greater than 18 years,
- left ventricular ejection fraction less than or equal to 35%,
- stable on standard HF medications, and
- optimal medical therapy.
You may not qualify if…
- major cardiovascular events,
- procedures in the last 6 months,
- dementia,
- presence of cardiovascular diseases that may lead to harm if the patient took part in the study (congenital heart disease, long QT syndrome, hypertrophic cardiomyopathy, active myocarditis).
Where it is running
- Columbia University Medical Center — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.